Surgery May Worsen Pleural Mesothelioma Survival Outcomes Surgery May Worsen Pleural Mesothelioma Survival Outcomes
There has been little improvement in systemic treatment of early-stage, resectable mesothelioma.MDedge News
Source: Medscape Medical News Headlines - September 14, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

MDMA Therapy for PTSD Inches Closer to U.S. Approval
Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.
Source: NYT Health - September 14, 2023 Category: Consumer Health News Authors: Rachel Nuwer Tags: Research Post-Traumatic Stress Disorder Therapy and Rehabilitation Drugs (Pharmaceuticals) Ecstasy (Drug) Psychiatry and Psychiatrists Drug Enforcement Administration Food and Drug Administration MAPS Public Benefit Corporation your-feed Source Type: news

Cancer patients missing out on breakthrough treatment as UK falls 'behind the pack', experts warn
Cancer experts told MPs today that pharmaceutical companies are shying away from launching new clinical trials in the UK for the first time due to being 'mired' in paperwork.
Source: the Mail online | Health - September 14, 2023 Category: Consumer Health News Source Type: news

Interventions Can Increase Adjuvant Endocrine Treatment Adherence
THURSDAY, Sept. 14, 2023 -- Lowering medication costs and some psychosocial and reminder interventions show the most promise for promoting adjuvant endocrine therapy (AET) adherence in breast cancer survivors, according to a review published online...
Source: Drugs.com - Pharma News - September 14, 2023 Category: Pharmaceuticals Source Type: news

MDMA Therapy for PTSD Inches Closer to U.S. Approval
MDMA pills used in a study on the drug’s effectiveness as a treatment for post-traumatic stress disorder in veterans. Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment. MDMA-assisted therapy…#mdma #ecstasy #berrayazarklosinski #naturemedicine #stephenxenakis #molly #schedule1 #rickdoblin #maps #mapspbc
Source: Reuters: Health - September 14, 2023 Category: Consumer Health News Source Type: news

AI startup Carenostics raises $5 million in Seed funding led by M13 to transform healthcare through earlier diagnosis and treatment of chronic disease patients
Carenostics brings together the first team to ever deploy AI at 1,000+ health systems to now tackle the underdiagnosis, undertreatment, and health inequities of chronic disease. NEW YORK, Sept. 14, 2023 /PRNewswire-PRWeb/ -- Carenostics, a pioneering healthcare AI startup tackling...
Source: PRWeb: Medical Pharmaceuticals - September 14, 2023 Category: Pharmaceuticals Tags: VEN FNC Source Type: news

2024 Breakthrough Prizes Announced: Cystic Fibrosis Pioneers Awarded $3 Million
Researchers at Vertex Pharmaceuticals were honored for their revolutionary work in the treatment of genetic disorder, along with other scientists in biology, physics and mathematics.
Source: Forbes.com Healthcare News - September 14, 2023 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Billionaires /worlds-billionaires Editors' Pick editors-pick technology alexknappblog premium Source Type: news

NICE to recommend rimegepant as first acute migraine treatment
NICE has approved rimegepant as the first treatment for acute migraine, in draft guidance published today. Around 13,000 could benefit from rimegepant (Vydura, Pfizer), said NICE after signing off its use in adults who have tried at least two triptans but they did not work well enough. It can also be used for those in... Read moreThe post NICE to recommend rimegepant as first acute migraine treatment appeared first on Nursing in Practice.
Source: Nursing in Practice - September 14, 2023 Category: Nursing Authors: Wiliam Hunter Tags: Clinical Latest news Women's health Source Type: news

Doctor recommends at-home migraine treatment that has no side effects
A doctor has revealed an at-home hack that could help relieve your migraine without any side effects.
Source: Daily Express - Health - September 14, 2023 Category: Consumer Health News Source Type: news

HHS: Discrimination on the Basis of Disability in Health and Human Service Programs or Activities
Notice of proposed rule from the U.S. Department of Health and Human Services (HHS) Office of Civil Rights (OCR) proposing new provisions that clarify existing requirements under section 504 prohibiting recipients of financial assistance from HHS from discriminating on the basis of disability in their programs and activities. Among other things, the proposed rule includes new requirements prohibiting discrimination in the areas of medical treatment; the use of value assessments; and web, mobile, and kiosk accessibility. This proposed rule would also update the definition of disability and other provisions to ensure consis...
Source: Federal Register updates via the Rural Assistance Center - September 14, 2023 Category: Rural Health Source Type: news

Rimegepant: New treatment for migraine attacks on NHS to benefit thousands
The treatment has been recommended by health experts and will soon be available on the NHS.
Source: BBC News | Health | UK Edition - September 14, 2023 Category: Consumer Health News Source Type: news

New treatment for migraine attacks on NHS to benefit thousands
The treatment has been recommended by health experts and will soon be available on the NHS.
Source: BBC News | Health | UK Edition - September 14, 2023 Category: Consumer Health News Source Type: news

Hope for thousands as NHS approves drug for acute migraine
First and only Nice-recommended medicine could ‘alleviate misery’ of condition in England and WalesNHS health advisers have approved the first treatment foracute migraine in a decision that promises to bring relief to about 13,000 people.The National Institute of Health and Clinical Excellence (Nice) has recommended a drug called rimegepant, also known as Vydura, which is made by Pfizer.Continue reading...
Source: Guardian Unlimited Science - September 13, 2023 Category: Science Authors: Denis Campbell Health policy editor Tags: Health NHS Neuroscience UK news Society England Wales Source Type: news

One in workers receiving fertility treatment quit their jobs over 'way they were treated', survey suggests
Researchers surveyed 2,000 people in the UK who have had fertility treatment in the past five years, such as IVF.
Source: the Mail online | Health - September 13, 2023 Category: Consumer Health News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20